New U.S. Rule Mandates Breast Density Notifications After Mammograms
The FDA requires mammography centers to inform women of breast density, sparking debate over additional cancer screening needs.
Overview
- Breast density notifications are now mandatory nationwide, though 39 states already had similar requirements.
- Dense breast tissue can obscure cancer detection on mammograms and slightly increases cancer risk.
- Experts disagree on the necessity of additional imaging tests like ultrasounds or MRIs for women with dense breasts.
- Insurance coverage for supplemental screenings varies, with potential high out-of-pocket costs for patients.
- Some health advocates express concern that the notifications might lead to confusion and unnecessary anxiety among women.